Access
To read this story in full you will need to login or make a payment (see right).
News
Nature 408, 630 (7 December 2000) | doi:10.1038/35047251
Open Innovation Challenges
-
Single-cell Analysis Platform
This Challenge is looking for novel approaches to analyzing changes at a single-cell level. This is...
-
Novel Approaches to Protecting Maize from Insect Damage
The Seeker is looking for novel approaches to protecting maize from insect damage. This Challenge re...
- More Challenges
- Powered by:
nature jobs
Paleobiologist / Biogeochemist
- University of Cincinnati
- Cincinnati, Ohio, USA
Postdoctoral Research Fellows
- Northwestern University
- Chicago, Illinois, United States
Xenotransplantation opponents take FDA to court
Paul Smaglik
Opponents of xenotransplantation research have begun a lawsuit against the US Food and Drug Administration (FDA), demanding that more information be made public about experiments in which humans receive transplants of animal tissue.The Campaign for Responsible Transplantation, which filed the lawsuit, says adverse events from xenotransplantation have been reported in journals and at public meetings hosted by the FDA, but the agency has refused to release all the data from these trials.
To read this story in full you will need to login or make a payment (see right).
